VIOXX (Rofecoxib) FDA INFORMATION

The FDA issued several warnings concerning Vioxx related side effects before the drug was removed from the market.. The links below will redirect you to these warnings on the FDA website.

• 2001 Merck Vioxx VIGOR Study
• 2001 Vioxx Advertising Warning Letter
• 2002 FDA Vioxx Talk Paper
• 2002 Merck Vioxx Dear Doctor Letter
• 2002 Vioxx Safety Label Update
• 2004 FDA Vioxx Recall Advisory
• 2004 FDA Vioxx COX II Q&A
• 2004 FDA Statement on Vioxx
• 2004 FDA Vioxx David Graham Statement
• 2004 Vioxx- Drug Safety Controversy
• 2005 FDA Vioxx Timeline
• 2005 FDA-Vioxx Cardiovascular Safety

Generic Name
Rofecoxib
Date Approved
May 20, 1999
Manufacturer
Merck & Co.
Status
Withdrawn 9/30/04
Approved Uses
Arthritis
Muscle pain
Off Label Uses
Bone pain
Muscle pain
General pain
Serious Side Effects
Heart attacks
Blood clots
Stroke
Related Topics
Bextra
Celebrex
Mobic
Blood Clots
Heart Attacks
Stroke
Defective Drugs
Diseases